Genotypic analysis of meningococcal factor h-binding protein from non-culture clinical specimens.

Factor H-Binding Protein (fHbp) is an outer membrane protein antigen included in two novel meningococcal group B vaccines and, as such, is an important typing target. Approximately 50% of meningococcal disease cases in England and Wales are confirmed using real-time PCR on non-culture clinical speci...

Full description

Saved in:
Bibliographic Details
Main Authors: Stephen A Clark, Jay Lucidarme, Lynne S Newbold, Ray Borrow
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089921&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849720244360183808
author Stephen A Clark
Jay Lucidarme
Lynne S Newbold
Ray Borrow
author_facet Stephen A Clark
Jay Lucidarme
Lynne S Newbold
Ray Borrow
author_sort Stephen A Clark
collection DOAJ
description Factor H-Binding Protein (fHbp) is an outer membrane protein antigen included in two novel meningococcal group B vaccines and, as such, is an important typing target. Approximately 50% of meningococcal disease cases in England and Wales are confirmed using real-time PCR on non-culture clinical specimens only. Protocols for typing fHbp from this subset of cases have not yet been established. Here we present a nested PCR-based assay designed to amplify and sequence fHbp from non-culture clinical specimens. From analytical sensitivity experiments carried out using diluted DNA extracts, an estimated analytical sensitivity limit of 6 fg/µL of DNA (<3 genome copies/µL) was calculated. The sensitivity of the assay was shown to be comparable to the ctrA-directed real-time PCR assay currently used to confirm invasive disease diagnoses from submitted clinical specimens. A panel of 96 diverse, patient-matched clinical specimen/isolate pairs from invasive disease cases was used to illustrate the breadth of strain coverage for the assay. All fHbp alleles sequenced from the isolates matched those derived from previous whole genome analyses. The first-round PCR primer binding sites are highly conserved, however an exceptional second-round PCR primer site mismatch in one validation isolate prevented amplification. In this case, amplification from the corresponding clinical specimen was achieved, suggesting that the use of a nested PCR procedure may compensate for any minor mismatches in round-two primer sites. The assay was successful at typing 91/96 (94.8%) of the non-culture clinical specimens in this study and exhibits sufficient sensitivity to type fHbp from the vast majority of non-culture clinical specimens received by the Meningococcal Reference Unit, Public Health England.
format Article
id doaj-art-32bd460f8cb84a15b63a051047ff55f8
institution DOAJ
issn 1932-6203
language English
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-32bd460f8cb84a15b63a051047ff55f82025-08-20T03:11:58ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0192e8992110.1371/journal.pone.0089921Genotypic analysis of meningococcal factor h-binding protein from non-culture clinical specimens.Stephen A ClarkJay LucidarmeLynne S NewboldRay BorrowFactor H-Binding Protein (fHbp) is an outer membrane protein antigen included in two novel meningococcal group B vaccines and, as such, is an important typing target. Approximately 50% of meningococcal disease cases in England and Wales are confirmed using real-time PCR on non-culture clinical specimens only. Protocols for typing fHbp from this subset of cases have not yet been established. Here we present a nested PCR-based assay designed to amplify and sequence fHbp from non-culture clinical specimens. From analytical sensitivity experiments carried out using diluted DNA extracts, an estimated analytical sensitivity limit of 6 fg/µL of DNA (<3 genome copies/µL) was calculated. The sensitivity of the assay was shown to be comparable to the ctrA-directed real-time PCR assay currently used to confirm invasive disease diagnoses from submitted clinical specimens. A panel of 96 diverse, patient-matched clinical specimen/isolate pairs from invasive disease cases was used to illustrate the breadth of strain coverage for the assay. All fHbp alleles sequenced from the isolates matched those derived from previous whole genome analyses. The first-round PCR primer binding sites are highly conserved, however an exceptional second-round PCR primer site mismatch in one validation isolate prevented amplification. In this case, amplification from the corresponding clinical specimen was achieved, suggesting that the use of a nested PCR procedure may compensate for any minor mismatches in round-two primer sites. The assay was successful at typing 91/96 (94.8%) of the non-culture clinical specimens in this study and exhibits sufficient sensitivity to type fHbp from the vast majority of non-culture clinical specimens received by the Meningococcal Reference Unit, Public Health England.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089921&type=printable
spellingShingle Stephen A Clark
Jay Lucidarme
Lynne S Newbold
Ray Borrow
Genotypic analysis of meningococcal factor h-binding protein from non-culture clinical specimens.
PLoS ONE
title Genotypic analysis of meningococcal factor h-binding protein from non-culture clinical specimens.
title_full Genotypic analysis of meningococcal factor h-binding protein from non-culture clinical specimens.
title_fullStr Genotypic analysis of meningococcal factor h-binding protein from non-culture clinical specimens.
title_full_unstemmed Genotypic analysis of meningococcal factor h-binding protein from non-culture clinical specimens.
title_short Genotypic analysis of meningococcal factor h-binding protein from non-culture clinical specimens.
title_sort genotypic analysis of meningococcal factor h binding protein from non culture clinical specimens
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089921&type=printable
work_keys_str_mv AT stephenaclark genotypicanalysisofmeningococcalfactorhbindingproteinfromnoncultureclinicalspecimens
AT jaylucidarme genotypicanalysisofmeningococcalfactorhbindingproteinfromnoncultureclinicalspecimens
AT lynnesnewbold genotypicanalysisofmeningococcalfactorhbindingproteinfromnoncultureclinicalspecimens
AT rayborrow genotypicanalysisofmeningococcalfactorhbindingproteinfromnoncultureclinicalspecimens